WHWK
Price:
$2.56
Market Cap:
$120.65M
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
Industry
Biotechnology
IPO Date
2017-08-01
Stock Exchange
NASDAQ
Ticker
WHWK
According to Whitehawk Therapeutics Inc’s latest financial reports and current stock price. The company's current Current Ratio is 20.41. This represents a change of 70.63% compared to the average of 11.96 of the last 4 quarters.
The mean historical Current Ratio of Whitehawk Therapeutics Inc over the last ten years is 4.84. The current 20.41 Current Ratio has changed 42.07% with respect to the historical average. Over the past ten years (40 quarters), WHWK's Current Ratio was at its highest in in the June 2025 quarter at 20.41. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
4.84
Median
4.15
Minimum
0.62
Maximum
9.90
Discovering the peaks and valleys of Whitehawk Therapeutics Inc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.49%
Maximum Annual Current Ratio = 9.90
Minimum Annual Increase = -50.62%
Minimum Annual Current Ratio = 0.62
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 3.59 | -23.95% |
| 2023 | 4.72 | -50.62% |
| 2022 | 9.56 | -3.50% |
| 2021 | 9.90 | 1.49% |
| 2020 | 0.62 | -2.33% |
The current Current Ratio of Whitehawk Therapeutics Inc (WHWK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
5.96
5-year avg
5.68
10-year avg
4.84
Whitehawk Therapeutics Inc’s Current Ratio is greater than Clene Inc. (1.58), greater than MacroGenics, Inc. (5.22), greater than Immix Biopharma, Inc. (1.53), greater than Tevogen Bio Holdings Inc. (0.31), greater than Ovid Therapeutics Inc. (4.24), greater than Zentalis Pharmaceuticals, Inc. (7.99), greater than Context Therapeutics Inc. (19.04), greater than Oncolytics Biotech Inc. (1.84), greater than Pliant Therapeutics, Inc. (13.93), greater than Atossa Therapeutics, Inc. (9.17),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.58 | $58.52M | |
| 5.22 | $87.30M | |
| 1.53 | $162.49M | |
| 0.31 | $83.79M | |
| 4.24 | $115.21M | |
| 7.99 | $101.15M | |
| 19.04 | $94.64M | |
| 1.84 | $98.42M | |
| 13.93 | $80.50M | |
| 9.17 | $98.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Whitehawk Therapeutics Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Whitehawk Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Whitehawk Therapeutics Inc's Current Ratio?
How is the Current Ratio calculated for Whitehawk Therapeutics Inc (WHWK)?
What is the highest Current Ratio for Whitehawk Therapeutics Inc (WHWK)?
What is the 3-year average Current Ratio for Whitehawk Therapeutics Inc (WHWK)?
What is the 5-year average Current Ratio for Whitehawk Therapeutics Inc (WHWK)?
How does the current Current Ratio for Whitehawk Therapeutics Inc (WHWK) compare to its historical average?